Optimizing Anti-TNF-α Therapy: Serum Levels of Infliximab and Adalimumab Are Associated With Mucosal Healing in Patients With Inflammatory Bowel Diseases

Bella Ungar, Idan Levy, Yarden Yavne, +8

Clinical Gastroenterology and Hepatology

InflammationRheumatologyMucosal HealingAnti-inflammatoryAutoimmune Disease +10

Addition of an Immunomodulator to Infliximab Therapy Eliminates Antidrug Antibodies in Serum and Restores Clinical Response of Patients With Inflammatory Bowel Disease

Shomron Ben‐Horin, Matti Waterman, Uri Kopylov, +6

Clinical Gastroenterology and Hepatology

InflammationChronic Inflammatory DiseasesAnti-inflammatoryAutoimmune DiseaseImmunology +8

The temporal evolution of antidrug antibodies in patients with inflammatory bowel disease treated with infliximab

Bella Ungar, Yehuda Chowers, Miri Yavzori, +6

Gut

The immunogenic part of infliximab is the F(ab')2, but measuring antibodies to the intact infliximab molecule is more clinically useful

Shomron Ben‐Horin, Miri Yavzori, Lior H. Katz, +7

Gut

Cross-immunogenicity: antibodies to infliximab in Remicade-treated patients with IBD similarly recognise the biosimilar Remsima

Shomron Ben‐Horin, Miri Yavzori, Itai Benhar, +7

Gut

Association of Vedolizumab Level, Anti-Drug Antibodies, and α4β7 Occupancy With Response in Patients With Inflammatory Bowel Diseases

Bella Ungar, Uri Kopylov, Miri Yavzori, +12

Clinical Gastroenterology and Hepatology

Inflammationα4β7 OccupancyMucosal ImmunologyImmunologyGastroenterology +5

Addition of an immunomodulator can reverse antibody formation and loss of response in patients treated with adalimumab

Bella Ungar, Uri Kopylov, Tal Engel, +11

Alimentary Pharmacology & Therapeutics

Detection of infliximab in breast milk of nursing mothers with inflammatory bowel disease

Shomron Ben‐Horin, Miri Yavzori, Uri Kopylov, +5

Journal of Crohn s and Colitis

Clinical utility of antihuman lambda chain-based enzyme-linked immunosorbent assay (ELISA) versus double antigen ELISA for the detection of anti-infliximab antibodies

Uri Kopylov, Yoav Mazor, Miri Yavzori, +7

Inflammatory Bowel Diseases

Induction infliximab levels among patients with acute severe ulcerative colitis compared with patients with moderately severe ulcerative colitis

Bella Ungar, Yoav Mazor, Roni Weisshof, +13

Alimentary Pharmacology & Therapeutics